My question is always how much are the real effective costs monthly/annually? The numbers always seem wild and are frequently quoted in thousands annually, so when you read things like:
> βThe amount of profit that they might be giving up [by capping costs] is relatively limited,β...
I am honest, I don't know what to believe, and I don't directly know anyone who uses insulin to even have any anecdota.
Tangent and I don't know how productive it is to discuss, does this have anything with the GLP-1s (Ozempic/Mounjaro et al.)?
The pressure is coming from legislation, and while there is no doubt lobbying going on, am I wrong that it doesn't feel like the same relentless pushback from the triumvirate? Is it just that there is critical mass to drive change, or is the bitter fight not worth it when they have potential weight management products applicable to a much wider audience?
> The pressure is coming from legislation, and while there is no doubt lobbying going on, am I wrong that it doesn't feel like the same relentless pushback from the triumvirate?
part of it is because medicare has to cap it because of biden. the other part is that california said "screw it we'll manufacture it and sell it at that price" so they didn't want to lose all money from the 6th largest economy in the world with the highest population in the us states.
> Is it just that there is critical mass to drive change
California is not manufacturing insulin. They are buying it from a non-profit drug maker that was already in the process of setting up a series of insulin production lines.
I am honest, I don't know what to believe, and I don't directly know anyone who uses insulin to even have any anecdota.
Tangent and I don't know how productive it is to discuss, does this have anything with the GLP-1s (Ozempic/Mounjaro et al.)?
The pressure is coming from legislation, and while there is no doubt lobbying going on, am I wrong that it doesn't feel like the same relentless pushback from the triumvirate? Is it just that there is critical mass to drive change, or is the bitter fight not worth it when they have potential weight management products applicable to a much wider audience?